Drug intelligence / Profile preview

leukocyte-platelet-rich fibrin

Development stage
Unknown
Lead developer
Universidad Austral de Chile
Modality
Cell Therapies
Administration
Implant
01

Overview

Leukocyte-platelet-rich fibrin (L-PRF) is an autologous, second-generation platelet concentrate biologic primarily used in oral, dental, and maxillofacial surgery to enhance wound healing and tissue regeneration. It is prepared by centrifuging a patient's own blood without anticoagulants to create a dense fibrin matrix enriched with leukocytes, platelets, and a high concentration of growth factors. This matrix acts as a biological scaffold that gradually releases bioactive molecules, such as platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-β), and vascular endothelial growth factor (VEGF), to promote angiogenesis and tissue repair. L-PRF is currently being evaluated by institutions like the Universidad Austral de Chile for applications such as preserving tooth socket tissue structure following third molar extractions.

Other names
leukocyte- and platelet-rich fibrinChoukroun's PRFL-PRF clot

Beyond the preview

Go deeper on leukocyte-platelet-rich fibrin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on leukocyte-platelet-rich fibrin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call